首页> 美国卫生研究院文献>other >Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research
【2h】

Pharmacotherapy for the Core Symptoms in Autistic Disorder: Current Status of the Research

机译:自闭症疾病中核心症状的药物疗法:研究现状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The current review covers extant literature on pharmacotherapy for core symptoms of autism. The core symptoms of autism include impairments in social interaction and communication, as well as the presence of restricted and repetitive behaviors. There are no known efficacious treatments for the core social symptoms, although effects on repetitive behaviors are indicated with some data. While studies of fenfluramine, secretin, opiates, and mood stabilizers generally find no effect, mixed results suggest more research is needed on antidepressants and atypical antipsychotics. Newer lines of research, including cholinergic and glutamatergic agents and oxytocin, will be of considerable interest in the future. However, research on the treatment of core symptoms is plagued by limitations in study design, statistical power and other issues inherent to the study of treatments for autism (e.g., heterogeneity of the disorder) that continue to prevent the elucidation of efficacious treatments.
机译:本篇综述涵盖了有关孤独症核心症状药物治疗的现有文献。自闭症的核心症状包括社交互动和沟通障碍,以及受限和重复的行为。尽管一些数据表明了对重复性行为的影响,但尚无有效的治疗核心社会症状的方法。虽然对芬氟拉明,促胰液素,鸦片制剂和情绪稳定剂的研究通常没有效果,但混合结果表明,需要进一步研究抗抑郁药和非典型抗精神病药。包括胆碱能和谷氨酸能药物以及催产素在内的新的研究领域将在未来引起人们的极大兴趣。然而,对核心症状的治疗研究受到自闭症治疗研究固有的研究设计,统计能力和其他问题(例如,疾病的异质性)的困扰,这些问题继续阻止对有效治疗方法的阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号